Showing results (51-60 of 97) with videos related to
Sort By:
Pageof 10
Arthritis and Rheumatism|February 5, 2005
SLC22A4 polymorphisms implicated in rheumatoid arthritis and Crohn's disease are not associated with rheumatoid arthritis in a Canadian Caucasian populationBill Newman, Richard F Wintle, Mark van Oene, et al.Arthritis Care & Research|November 11, 2017
Early Rheumatoid Arthritis Presentation, Treatment, and Outcomes in Aboriginal Patients in Canada: A Canadian Early Arthritis Cohort Study AnalysisSujay Nagaraj, Cheryl Barnabe, Orit Schieir, et al.Journal of Clinical Pharmacology|October 17, 2024
Pharmacokinetics and Safety of Intravenous Candidate Biosimilar CT-P47 and Reference Tocilizumab: A Randomized, Double-Blind, Phase 1 StudyMiwa Haranaka, Takashi Eto, Takanori Tanaka, et al.Annals of the Rheumatic Diseases|May 7, 2010
Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD studyEdward Keystone, Mark C Genovese, Lars Klareskog, et al.Rheumatology Advances in Practice|May 14, 2023
Impact of the COVID-19 pandemic on patients with rheumatoid arthritis: data from the Ontario Best Practices Research Initiative (OBRI)Matthew Wong-Pack, Elliot Hepworth, Mohammad Movahedi, et al.Clinical and Experimental Rheumatology|March 25, 2017
Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritisBindee Kuriya, Orit Schieir, Daming Lin, et al.Arthritis & Rheumatology (Hoboken, N.J.)|August 28, 2020
Improvements in Fatigue Lag Behind Disease Remission in Early Rheumatoid Arthritis: Results From the Canadian Early Arthritis CohortMelissa Holdren, Orit Schieir, Susan J Bartlett, et al.RMD Open|December 6, 2019
A quarter of patients time their early rheumatoid arthritis onset differently than physiciansLeah Ellingwood, Fatima Kudaeva, Orit Schieir, et al.Arthritis Care & Research|August 27, 2016
Predicting Low Disease State and Remission in Early Rheumatoid Arthritis in the First Six Months, Comparing the Simplified Disease Activity Index and European League Against Rheumatism Response Measures: Results From an Early Arthritis CohortMohammed A Omair, Edward Keystone, Vivian Bykerk, et al.Arthritis & Rheumatology (Hoboken, N.J.)|December 29, 2016
Effects of Baricitinib on Lipid, Apolipoprotein, and Lipoprotein Particle Profiles in a Phase IIb Study of Patients With Active Rheumatoid ArthritisJoel M Kremer, Mark C Genovese, Edward Keystone, et al.Pageof 10